502 results on '"Renzulli, M."'
Search Results
102. Transarterial chemoembolization in down-staging program for HCC prior to liver transplantation: the Bologna Work-in-progress experience
103. Outcomes and survival after TIPS positioning: a single center experience
104. Chemioembolizzazione transarteriosa nel protocollo di downstaging dell'epatocarcinoma prima del trapianto ortotopico di fegato: l'esperienza del gruppo di Bologna
105. DIAGNOSTICA PER IMMAGINI DEL PANCREAS
106. DIAGNOSTICA PER IMMAGINI DEL FEGATO
107. DIAGNOSTICA PER IMMAGINI DELLE VIE BILIARI
108. Transjugular intrahepatic portosystemic shunt (TIPS): our experience
109. Transjugular intrahepatic portosystemic shunt: elective management of acute bleeding varices in a pregnant woman
110. Trattamento mediante infusione intrarteriosa di Ittrio 90 dell'epatocarcinoma (HCC) inoperabile e metastasi epatiche da carcinoma colo-rettale:esperienza personale
111. La radiologia interventistica nel trattamento delle stenosi biliari post-trapianto di fegato (OLT): l'esperienza del gruppo di Bologna
112. Peripancreatic vascular anatomic variations: impact of radiological diagnosis with multidetector computer tomography (MDCT) on surgical strategy
113. Neoplasie solide del pancreas
114. Peripancreatic vascular anatomic variations: impact of radiological diagnosis with multidetector computer tomography (MDTC) on surgical strategy
115. Neuroendocrine pancreatic cancer: diagnoses and characterization with spiral computed tomography and nuclear magnetic resonance
116. Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma
117. Final analysis of the multicenter phase II 'Bologna 2002' study incorporating thalidomide-dexamethasone (thal-dex) into up-front double autologous stem-cell transplantation (ASCT) for multiple myeloma
118. Gene expression profiling (gep) of myeloma (MM) cells to predict attainment near complete response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed MM
119. INCORPORATION OF THALIDOMIDE INTO UP-FRONT DOUBLE AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE MYELOMA: PROGNOSTIC RELEVANCE OF BASELINE CYTOGENETIC ABNORMALITIES
120. Down regulation of TOPK, PBX3, SRPK, DDX21 and CLC genes in newly diagnosed early chronic phase chronic myeloid leukemia ptients treated with imatinib mesylate
121. A new abl kinase inhibitor (AMN107) has in vitro activity on CML Ph plus Blast cells resistant to imatinib
122. A novel 4-anilino-3-quinolinecarbonitrile dual sre and AbI kinase inhibitor (SKI-606) has in vitro activity on CML Ph plus Blast cells resistant to imatinib
123. Studies toward Taxuspine X, a potent Multidrug - Resistance Reversing Agent, via ring closing metathesis strategy
124. A combinatorial approach for the solid phase synthesis of 5,6-disubstituted pyrimidinones and pyrimidine derivatives
125. P972 SINGLE HEPATOCELLULAR CARCINOMA: IS TACE A VALID OPTION?
126. Appearance of combined hepatocellular cholangiocarcinoma in cirrhosis at contrast enhanced imaging techniques
127. Electrochemotherapy of head and neck cancer in elderly patients: a preliminary report
128. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study
129. Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”
130. 614 SPLENIC STIFFNESS ASSESSED BY ARFI (ACOUSTIC RADIATION FORCE IMAGING) CORRELATES WITH PORTAL PRESSURE IN CIRRHOSIS
131. T-23 Splenic stiffness assessed by ARFI (acoustic radiation force impulse) correlates with portal pressure in liver cirrhosis
132. 1001 RAPID, MARKED WASH OUT AT CONTRAST ENHANCED ULTRASOUND IN NODULES IN CIRRHOSIS SHOULD RAISE THE SUSPICION OF CHOLANGIOCARCINOMA
133. F.N.26 EFFICACY OF SUPERSELECTIVE TACE IN TREATMENT OF HCC
134. Factors predicting mortality after TIPS for refractory ascites: A single center experience
135. OUTCOMES AND SURVIVAL AFTER TIPS POSITIONING: A SINGLE CENTER EXPERIENCE
136. B497 Pathways Shared by t(4;14) and D13 positive MM Patients Impact Response to Velcade/Thalidomide/Dexamethasone
137. PA.212 CAPSULE ENDOSCOPY EXAMINATION: A PREVIEW BY AN ENDOSCOPIC NURSE AND A STAFF NURSE. PRELIMINARY RESULTS
138. Gene Expression Profiling (GEP) of Myeloma (MM) Cells To Predict Attainment (near) Complete Response to Primary Therapy with Thalidomide-Dexamethasone (Thali-Dex) for Newly Diagnosed MM.
139. Potential of multislice CT in the follow-up of Kawasaki coronary disease
140. MRI findings of small isolated congenital left ventricular diverticulum
141. Insuline-Like Growth Factor 1 Is over Expressed in Multiple Myeloma Plasma Cells and Regulates the Expression of the Insuline-Like Growth Factor 1 Receptor.
142. Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis.
143. Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by gene expression profiling (gep)
144. What happened to my liver lesion (Hepatic Sclerosed Hemangioma)? Let's not forget (radiological) history.
145. Unexpected newborns in the liver : hemangiomatosis onset after hepatic resection of a giant cavernous hemangioma.
146. Gastrointestinal: Bowel ischemia in a suspected coronavirus disease (COVID‐19) patient.
147. Yttrium-90 microsphere radioembolization for unresectable cholangiocarcinoma
148. What happened to my liver lesion (Hepatic sclerosed hemangioma)? let’s not forget (radiological) history
149. Magnetic resonance imaging (MRI) and computed tomography (CT) for cholangiocarcinoma
150. Staging of cholangiocarcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.